A. Michael Lincoff, M.D., Stephen J. Nicholls, M.B., B.S., Ph.D., Jeffrey S. Riesmeyer, M.D.,
Philip J. Barter, M.B., B.S., Ph.D., H. Bryan Brewer, M.D., Keith A.A. Fox, M.B., Ch.B., F.Med.Sci.,
C. Michael Gibson, M.D., Christopher Granger, M.D., Venu Menon, M.D., Gilles Montalescot, M.D., Ph.D., Daniel Rader, M.D., Alan R. Tall, M.B., B.S., Ellen McErlean, M.S.N., Kathy Wolski, M.P.H.,
Giacomo Ruotolo, M.D., Ph.D., Burkhard Vangerow, M.D., Govinda Weerakkody, Ph.D.,
Shaun G. Goodman, M.D., Diego Conde, M.D., Darren K. McGuire, M.D., M.H.Sc.,
Jose C. Nicolau, M.D., Jose L. Leiva‑Pons, M.D., Yves Pesant, M.D., Weimin Li, M.D.,
David Kandath, M.D., Simon Kouz, M.D., Naeem Tahirkheli, M.D., Denise Mason, B.S.N.,
and Steven E. Nissen, M.D., for the ACCELERATE Investigators*




Dr. Steve Nissen presents the results from the PRECISION trial!


Late Breaking Trials at AHA 2016


"Cardiovascular Outcomes with Celecoxib vs. Ibuprofen or Naproxen: The PRECISION Trial"


"Effect of Evolocumab on Progression of Coronary Atherosclerosis in Statin-Treated Patients: A Placebo-Controlled Intravascular Ultrasound Trial"


"Impact of Infusion of an ApoA-IMilano HDL Mimetic on Regression of Coronary Atherosclerosis in Acute Coronary Syndrome patients: the MILANO-PILOT Study"

Session Title: Insights from New Therapeutic Trials for Lipids
Session Date/Time: Tuesday Nov 15, 2016 10:45 AM - 12:00 PM
Presentation Time: 11:43am - 11:53am

Esperion announces its collaboration with C5Research on a phase III  trial for Bempedoic Acid. The Company intends to initiate the planned CVOT in statin intolerant patients who are at high risk for CV disease in the fourth quarter of 2016. The global CVOT - Cholesterol Lowering via BEmpedoic Acid, an ACL-inhibiting Regimen (CLEAR) Outcomes-will be conducted in cooperation with the Cleveland Clinic Coordinating Center for Clinical Research (C5Research), with Steven E. Nissen, MD, Department Chair, Cardiovascular Medicine, Cleveland Clinic, serving as study chairman. Click here for the entire press release.


On behalf of the ACCELERATE Trial Investigators, A. Michael Lincoff, MD presents at ESC 2016......

"Lipid Levels and CV Outcome with CETP Inhibition by
Evacetrapib in




Late Breaking STAMPEDE Results from ACC 2016!

Late Breaking GAUSS-3 Results from ACC 2016!

Late Breaking ACCELERATE Results from ACC 2016!


Microbiology of Cardiac Implantable Electronic Device Infections Online First

Ayman A. Hussein, MD; Yacoub Baghdy, MD; Oussama M. Wazni, MD; Michael P. Brunner, MD; Ghazal Kabbach, MD; Mingyuan Shao, MS; Steven Gordon, MD; Walid I. Saliba, MD; Bruce L. Wilkoff, MD; Khaldoun G. Tarakji, MD, MPH


ACC 2016 Poster Presentation:

Right Ventricular FDG-PET Uptake Suggests a Shift to Glycolytic Metabolism in the Setting of Right Ventricular Dysfunction Related to Pulmonary Arterial Hypertension.
Margaret  M. Park, Didem Uzunaslan, Srisakul Chirakarnjanakorn, Frank DiFilippo, Don Neumann, Christine L. Jellis, Charles Roach, Kristin B. Highland, James D. Thomas, Samar Farha, Serpil Erzurum, W.H. Wilson Tang






Non-invasive Volumetric Assessment of Aortic Atheroma: A Core Laboratory Validation Using Computed Tomography Angiography
Muhammad Hammadah • Mohammed Qintar • Steven E. Nissen • Julie St. John • Saqer Alkharabsheh • Motunrayo Mobolaji-Lawal • Femi Philip • Kiyoko Uno • Yu Kataoka • Brett Babb • Roman Poliszczuk • Samir R. Kapadia • E. Murat Tuzcu • Paul Schoenhagen • Stephen J. Nicholls • Rishi Puri


STAMPEDE: An Update for GIs About Bariatric Surgery for Type 2 Diabetes--Potential Implications for our practices by Ibrahim Hanouneh, MD


DIA 2014


PARTNER II - Trial Design